Furthermore, chemokine levels differed between patients with increased transaminase, AST, and ALT concentrations, suggesting a potential role in progressive liver damage in patients with MASLD (Supplemental Figure S3). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.